WEBINAR INSTANT STREAMING ACCESS

The FDA Medical Device File (DHF, DMR, DHR, Market Authorizations)

and EU MDR Technical Documentation

This course explains how FDA device files and EU MDR technical documentation truly align — helping teams structure DHF, DMR, DHR, and Technical Files in a way that supports global approvals, parallel development, and smoother audits.

As medical device companies expand beyond a single market, documentation becomes the silent deal-breaker. Teams often assume FDA and EU files are fundamentally different — only to discover late in development that they overlap in purpose, diverge in structure, and are audited very differently. This webinar clears the confusion by laying out how FDA medical device files and EU MDR technical documentation really compare, connect, and evolve.

The session explains how Design History Files, Device Master Records, and Device History Records function across the full product lifecycle — and how those same concepts reappear under EU MDR as technical documentation, essential requirements, and declarations of conformity. You’ll see how design control differs from a “snapshot in time” file, why some documents must remain living records, and where teams commonly misalign their US and EU submissions. QMSR-driven terminology changes are addressed directly, so documentation strategies remain future-proof.

If your teams are juggling FDA inspections and Notified Body audits, this webinar brings structure and clarity. It shows how to build documentation in parallel, reduce rework, and support global submissions without duplicating effort. You’ll leave with a clearer mental model of what each file is meant to prove — and how to keep regulators on both sides of the Atlantic satisfied.

Key Areas Covered:

  • QMSR terminology shifts and their impact on DHF, DMR, and DHR expectations 
  • The Design History File as a lifecycle system — not a static design archive
  • EU MDR Technical Documentation and Design Dossier intent versus U.S. design control philosophy
  • Design Control versus “product snapshot” documentation — where companies most often fail
  • Practical DHF, DMR, and DHR structure, including lot and batch record integration
  • Technical File / Design Dossier expected contents under EU MDR Annex II & III
  • Parallel documentation strategies that support global submissions and concurrent development
  • How FDA investigators and Notified Bodies differ in file review, audit focus, and evidence expectations

Course Director

John E. Lincoln
John E. Lincoln brings decades of hands-on experience guiding global device companies through FDA and EU documentation, audits, and remediation. His perspective bridges design, manufacturing, and regulatory strategy — translating complex requirements into documentation systems that actually work under inspection pressure.

What Happens After You Register

Once registered, the process is fully coordinated by our events team.
  • Onboarding/Welcome is sent by email
  • Login info is shared a day in advance, so you’re set before the session
  • Handouts and materials (where applicable) are shared before start
  • The session is instructor-led via Webex
  • The session includes live participation and Q&A
  • Certificates of completion are issued after the training
  • If you select live + recording, post-session access is provided via our learning environment – TalkFDA
  • Event support is available throughout for any access or logistics needs
  • After completing your purchase, access is provided in a structured and supported format.

  • Onboarding/Welcome is sent by email with next steps
  • The full session recording is made available through our learning environment – TalkFDA
  • Access is available shortly after purchase, so you can begin without delay
  • Recording access includes the complete presentation and instructor-led discussion
  • Certificates of completion are issued upon course completion
  • Support is available for any access or technical assistance
  • Your Learning Environment
    This training is delivered within a professionally managed learning environment.

  • Many organizations rely on this structure to support repeatable, audit-ready learning
  • Sessions are developed and led by experienced industry practitioners
  • Delivery and access are supported through a structured digital system, not ad-hoc file sharing
  • Where applicable, post-session access is managed through TalkFDA, our learning environment
  • This approach ensures consistency, continuity, and traceability across trainings
  • MD3259

    © All rights reserved